GRACE THERAPEUTICS, INC.

Profile

Company Names

GRACE THERAPEUTICS, INC.
ACASTI PHARMA INC.

Addresses

103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ 08540

2572 BOUL. DANIEL-JOHNSON, 2ND FLOOR, LAVAL, A8 H7T 2R3

545 PROMENDE DU CENTROPOLIS, SUITE 100, LAVAL, A8 H7T 0A3

225 PROMENADE DU CENTROPOLIS, SUITE 200, LAVAL, A8 H7T 0B3

Phone Numbers

609-322-1602
450-686-4555
(450) 686-4555
450-687-2262

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

QUEBEC, CANADA

Total Amount Raised:

$23,042,881.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-02-10 
$14,999,985.00 
$30,000,203.00 
$15,000,218.00 
Equity 
3
2023-09-25 
$7,499,793.00 
$15,116,786.00 
$7,616,993.00 
Equity 
2
2018-05-09 
$372,637.00 
$837,546.00 
$464,909.00 
Equity 
1
2011-08-18 
$170,466.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEAN-MARIE (JOHN) 
 
CANAN 
DIRECTOR
ACASTI PHARMA INC.
RODERICK 
N. 
CARTER 
DIRECTOR
ACASTI PHARMA INC.
MICHEL 
 
CHARTRAND 
DIRECTOR
NEPTUNE TECHNOLOGIES + BIORESSOURCES INC.   |  ACASTI PHARMA INC.
JANELLE 
 
D-ALVISE 
EXECUTIVE OFFICER, DIRECTOR
ACASTI PHARMA INC.
CARRIE 
 
D-ANDREA 
EXECUTIVE OFFICER
ACASTI PHARMA INC.   |  GRACE THERAPEUTICS, INC.
A. BRIAN 
 
DAVIS 
DIRECTOR
TENGION INC   |  STRONGBRIDGE BIOPHARMA PLC   |  GRACE THERAPEUTICS, INC.
ROBERT J. 
 
DELAVERSANO 
EXECUTIVE OFFICER
GRACE THERAPEUTICS, INC.
RONALD 
 
DENIS 
DIRECTOR
NEPTUNE TECHNOLOGIES + BIORESSOURCES INC.   |  ACASTI PHARMA INC.   |  NEPTUNE WELLNESS SOLUTIONS INC.
MICHAEL 
 
DERBY 
DIRECTOR
VALIANT VINEYARDS INC   |  CASTLE CREEK PHARMACEUTICALS, LLC   |  CASTLE CREEK PHARMACEUTICAL HOLDINGS, INC.   |  PAXMEDICA, INC.   |  VISIOX PHARMA, LLC   |  ACASTI PHARMA INC.
BRIAN 
 
FORD 
EXECUTIVE OFFICER
TELESTA THERAPEUTICS INC.   |  URS CCP OZ II LLC   |  FIRST CITIZENS BANCSHARES, INC./TX   |  WAYFORD IP CCP INVESTORS LLC   |  WAYFORD CONCORD CCP INVESTORS LLC   |  DANDIPRAT REAL ESTATE HOLDINGS LLC   |  ACASTI PHARMA INC.   |  AA RIVERBLUE P3 CCP INVESTORS, LLC   |  RB P2 CCP INVESTORS, LLC
MARTIN 
 
GODBOUT 
DIRECTOR
ASMACURE, INC.   |  METHYLGENE INC.   |  ACASTI PHARMA INC.
HENRI 
 
HARLAND 
EXECUTIVE OFFICER, DIRECTOR
NEPTUNE TECHNOLOGIES + BIORESSOURCES INC.   |  ACASTI PHARMA INC.
XAVIER 
 
HARLAND 
EXECUTIVE OFFICER
ACASTI PHARMA INC.
VIMAL 
 
KAVURU 
DIRECTOR
ACASTI PHARMA INC.   |  GRACE THERAPEUTICS, INC.
PRASHANT 
 
KOHLI 
DIRECTOR, EXECUTIVE OFFICER
ACASTI PHARMA INC.   |  GRACE THERAPEUTICS, INC.
S. GEORGE 
 
KOTTAYIL 
DIRECTOR
GRACE THERAPEUTICS, INC.
AMRESH 
 
KUMAR 
EXECUTIVE OFFICER
ACASTI PHARMA INC.   |  GRACE THERAPEUTICS, INC.
MARC 
 
LEBEL 
DIRECTOR
ACASTI PHARMA INC.   |  FRX POLYMERS, INC.
DR. R. LOCH 
 
MACDONALD 
EXECUTIVE OFFICER
ACASTI PHARMA INC.   |  GRACE THERAPEUTICS, INC.
EDWARD 
 
NEUGEBOREN 
DIRECTOR
KINEMED INC   |  LEDGEMONT ENERGY PARTNERS LP   |  GRACE THERAPEUTICS, INC.
LINDA 
P. 
O-KEEFE 
EXECUTIVE OFFICER
PEDIATRIC BIOSCIENCE, INC.   |  ACASTI PHARMA INC.
DONALD 
 
OLDS 
DIRECTOR
TELESTA THERAPEUTICS INC.   |  ACASTI PHARMA INC.   |  GOODFOOD MARKET CORP.   |  RETENSION PHARMACEUTICALS, INC.   |  RESPONSE PHARMACEUTICALS, INC.
TINA 
 
SAMPALIS 
EXECUTIVE OFFICER
NEPTUNE TECHNOLOGIES + BIORESSOURCES INC.   |  ACASTI PHARMA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-25
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2025-02-10 
2023-10-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2023-09-25 
2018-05-25
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-05-09 
2011-09-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
TD SECURITIES (USA) LLC
18476
MACKIE RESEARCH CAPITAL CORPORATION
NONE
MACKIE RESEARCH USA INC.
39670